Alpha Cognition (OTC:ACOGF) Shares Up 4.2%

Alpha Cognition Inc. (OTC:ACOGFGet Free Report) shares rose 4.2% during mid-day trading on Wednesday . The company traded as high as C$0.59 and last traded at C$0.56. Approximately 20,001 shares traded hands during trading, a decline of 49% from the average daily volume of 38,999 shares. The stock had previously closed at C$0.54.

Alpha Cognition Price Performance

The stock has a market capitalization of C$71.43 million, a P/E ratio of -4.32 and a beta of 2.96. The stock’s fifty day moving average price is C$0.53 and its 200 day moving average price is C$0.54.

Alpha Cognition Company Profile

(Get Free Report)

Alpha Cognition Inc, a clinical stage biopharmaceutical company, focuses on developing treatments for Alzheimer's disease and amyotrophic lateral sclerosis (ALS). It develops ALPHA-1062, an acetylcholine esterase inhibitor for the treatment of dementia of the Alzheimer's type and mild traumatic brain injury; ALPHA-0602, a gene therapy for the treatment of ALS; and ALPHA-0702 and ALPHA-0802, a granulin epithelin motifs for the treatment of neurodegenerative diseases.

See Also

Receive News & Ratings for Alpha Cognition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Cognition and related companies with MarketBeat.com's FREE daily email newsletter.